KCNH1 and leukemia: Therefore, HERG channels could have broader therapeutic applications in leukemia than hEag1, but its ubiquitous expression throughout the body and its crucial role in cardiac repolarization are challenging problems for a HERG-based therapy because severe side effects like fatal arrhythmias can occur [32].